<DOC>
	<DOC>NCT02428595</DOC>
	<brief_summary>Multi-center, prospective, within-subject control, open label clinical trial to evaluate the durability of the safety and effectiveness of the Eclipse™ System after 3 and 12 months of use.</brief_summary>
	<brief_title>A Clinical Evaluation of the Eclipse™ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>Abbreviated History of FI for at least 6 months Subject willing and able to give written informed consent to participate in the study Subject can read, write and communicate fluently in English Subject willing and able to comply with visit schedule Subject is able to physically manage the insertion and removal of the Insert Abbreviated Vaginal childbirth within the last 18 months Currently pregnant or planning pregnancy during the study period Acute infections or genitourinary injuries that would impact comfortable device use Current treatment for FI other than medical management Removal or diversion of any portion of the bowel Recent urogenital or colorectal surgeries Chronic abdominal pain in absence of diarrhea Chronic (&gt;6 mos) rectal, anal or pelvic pain Chronic watery diarrhea, unmanageable by drugs or diet Inflammatory Bowel Disease (IBD) such as Chron's or Ulcerative Colitis Rectal prolapse (mucosal or full thickness) Grade III or IV hemorrhoids Pelvic organ prolapse beyond the plane of the hymen Concurrent use of intravaginal pessary or other device Anal or pelvic malignancy within last 5 years History of pelvic irradiation for cancer Other significant medical or lifestyle factors that could confound the interpretation of the primary endpoint or increase subject risk</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>